We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.17B
AUM Growth
-$6.39M
(-0.29%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
36.67%
Holding
3,684
New
390
Increased
1,387
Reduced
1,049
Closed
222
Avg Time Held Equity + Options
3.1
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Select Dividend ETF
IDV
|
+$42.9M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$36.8M |
| 3 |
Corcept Therapeutics
CORT
|
+$28.1M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$20.3M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$24.4M |
| 2 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 3 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$21.7M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$17.5M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.55% |
| 2 | Technology | 12.45% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 8.7% |
| 5 | Consumer Discretionary | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3351
ePlus
PLUS
$2.48B
| $0 | ﹤0.01% |
7
+1
| +17% | +$49 |
2020 Q4
7 quarters
|
|
|
PLYM
3352
DELISTED
Plymouth Industrial REIT
PLYM
| $0 | ﹤0.01% |
+17
| New | +$329 |
2022 Q3
0 quarters
|
|
3353
PennyMac Mortgage Investment
PMT
$616M
| $0 | ﹤0.01% |
+23
| New | +$336 |
2022 Q3
0 quarters
|
|
3354
PMV Pharmaceuticals
PMVP
$69M
| $0 | ﹤0.01% |
+11
| New | +$159 |
2022 Q3
0 quarters
|
|
3355
Profound Medical
PROF
$231M
| $0 | ﹤0.01% |
30
| – | – |
2022 Q1
2 quarters
|
|
3356
Purple Innovation
PRPL
$9.9M
| – | – |
-11
| Closed | -$1K | – |
|
3357
Peraso
PRSO
$5.75M
| – | – |
0
| – | – |
2022 Q2
1 quarter
|
|
3358
Invesco S&P SmallCap Industrials ETF
PSCI
$266M
| – | – |
-300
| Closed | -$24K | – |
|
3359
Invesco S&P SmallCap Financials ETF
PSCF
$26.3M
| – | – |
-500
| Closed | -$24K | – |
|
3360
Invesco S&P SmallCap Materials ETF
PSCM
$19.7M
| – | – |
-400
| Closed | -$23K | – |
|
3361
Paysafe
PSFE
$296M
| – | – |
-8
| Closed | – | – |
|
3362
Brookfield Real Assets Income Fund
RA
$644M
| $0 | ﹤0.01% |
+7
| New | +$134 |
2022 Q3
0 quarters
|
|
3363
Ribbon Communications
RBBN
$254M
| – | – |
-1,932
| Closed | -$6K | – |
|
3364
Republic Bancorp
RBCAA
$1.8B
| – | – |
-376
| Closed | -$16.7K | – |
|
3365
DELISTED
Vicarious Surgical
RBOT
| $0 | ﹤0.01% |
1
| – | – |
2022 Q2
1 quarter
|
|
3366
Avita Medical
RCEL
$415M
| $0 | ﹤0.01% |
40
| – | – |
2021 Q1
6 quarters
|
|
3367
Replimune Group
REPL
$1.11B
| $0 | ﹤0.01% |
14
+8
| +133% | +$153 |
2022 Q2
1 quarter
|
|
3368
Rigetti Computing
RGTI
$4.22B
| $0 | ﹤0.01% |
30
| – | – |
2021 Q4
3 quarters
|
|
3369
Transocean
RIG
$6.15B
| $0 | ﹤0.01% |
200
| – | – |
2019 Q1
14 quarters
|
|
3370
Relay Therapeutics
RLAY
$3.79B
| $0 | ﹤0.01% |
12
| – | – |
2022 Q2
1 quarter
|
|
3371
Relmada Therapeutics
RLMD
$341M
| $0 | ﹤0.01% |
+4
| New | +$111 |
2022 Q3
0 quarters
|
|
3372
DELISTED
RE/MAX Holdings
RMAX
| $0 | ﹤0.01% |
13
-52
| -80% | -$1.24K |
2020 Q1
10 quarters
|
|
3373
Regional Management Corp
RM
$318M
| – | – |
-10
| Closed | – | – |
|
3374
Rimini Street
RMNI
$384M
| – | – |
-48
| Closed | – | – |
|
|
RNAM
3375
DELISTED
Avidity Biosciences
RNAM
| $0 | ﹤0.01% |
27
+6
| +29% | +$115 |
2022 Q2
1 quarter
|
|
Similar funds
Parallel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Parallel Advisors held 3,684 positions worth $2.17B, down 0.29% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $112M of net new capital in Q3 2022, opening 390 new positions and adding to 1,387 existing holdings. Its largest new stake was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $24.4M trimmed.
- Parallel Advisors's largest Q3 2022 buy was iShares MSCI USA Equal Weighted ETF: 17,208 shares worth $1.15M.
- Parallel Advisors added most to iShares International Select Dividend ETF in Q3 2022, an estimated $42.9M increase.
- Parallel Advisors's biggest Q3 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $24.4M.
- Parallel Advisors fully exited Sanderson Farms Inc in Q3 2022, selling an estimated $503K.
- Parallel Advisors's ten largest holdings make up 37% of its $2.17B portfolio in Q3 2022.
- Parallel Advisors opened 390 new positions and closed 222 in Q3 2022.
- Parallel Advisors's portfolio value fell 0.29% quarter-over-quarter to $2.17B.
Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.